You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Treatment naïve and Treatment experienced

Showing 1 - 25 of 5,335
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glycogen Storage Disease Type II Infantile Onset Trial in Gainesville (Cipaglucosidase alfa (ATB200), Miglustat (AT2221))

Recruiting
  • Glycogen Storage Disease Type II Infantile Onset
  • Gainesville, Florida
    University of Florida Clinical Research Center
Jan 18, 2023

Helicobacter Pylori Trial in Shibin Al Kawm (Naïve patients - ACO therapy, Naïve patients - LNDL therapy, Naïve patients - MNDL

Recruiting
  • Helicobacter Pylori
  • Naïve patients - ACO therapy
  • +4 more
  • Shibīn Al Kawm, Menoufia, Egypt
    National Liver institute - Menoufia University
Dec 21, 2021

Primary Immunodeficiency Trial in United States (IGSC 20%)

Completed
  • Primary Immunodeficiency
  • IGSC 20%
  • Birmingham, Alabama
  • +11 more
Nov 2, 2022

Zepatier in Patients With Substance Use

Active, not recruiting
  • Hepatitis C
  • +3 more
  • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
  • Chicago, Illinois
    University of Illinois at Chicago
Jun 28, 2022

HIV-1-infection Trial in Kenya (Dolutegravir)

Completed
  • HIV-1-infection
  • Kiambu, Kenya
  • +3 more
Jan 26, 2022

Japanese Encephalitis Trial in Liverpool (IMOJEV)

Enrolling by invitation
  • Japanese Encephalitis
  • IMOJEV
  • Liverpool, United Kingdom
    Liverpool University Hospitals NHS Foundation Trust
Sep 28, 2021

Hepatitis C Virus Trial (ABT-450/r/ABT-267, Ribavirin)

Completed
Has Results
  • Hepatitis C Virus
  • (no location specified)
Jul 28, 2021

Atypical Hemolytic Uremic Syndrome (aHUS) Trial in Worldwide (Ravulizumab)

Active, not recruiting
Has Results
  • Atypical Hemolytic Uremic Syndrome (aHUS)
  • Ravulizumab
  • Aurora, Colorado
  • +19 more
Nov 16, 2022

Primary Immunodeficiency Trial in United States (IGSC 20% daily push versus every 2 weeks pump, IGSC 20% daily push versus once

Withdrawn
  • Primary Immunodeficiency
  • IGSC 20% daily push versus every 2 weeks pump
  • +3 more
  • South Bend, Indiana
  • +3 more
Apr 8, 2020

Multiple Sclerosis Trial (Natalizumab)

Not yet recruiting
  • Multiple Sclerosis
  • (no location specified)
Jun 21, 2023

Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (GSK1349572, Raltegravir, GSK1349572 Placebo)

Completed
Has Results
  • Infection, Human Immunodeficiency Virus
  • HIV Infections
  • Birmingham, Alabama
  • +180 more
Mar 14, 2022

NSCLC Trial in Shanghai (IN10018, Furmonertinib)

Recruiting
  • NSCLC
  • Shanghai, China
    Shanghai Pulmonary Hospital
Aug 8, 2023

HIV Trial in Puerto Rico, South Africa, United States (ATV, Ritonavir)

Completed
Has Results
  • HIV Infections
  • Birmingham, Alabama
  • +35 more
Nov 3, 2021

Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)

Not yet recruiting
  • Non-Muscle- Invasive Bladder Cancer
  • Durvalumab
  • BCG
  • (no location specified)
Jul 5, 2023

Diabetic Macular Edema, Pars Plana Vitrectomy, Conbercept Trial in Tianjin (Vitrectomy combined with ILM peeling, Conbercept

Not yet recruiting
  • Diabetic Macular Edema
  • +2 more
  • Vitrectomy combined with ILM peeling
  • Conbercept intravitreal injection
  • Tianjin, Tianjin, China
    Tianjin medical university eye hosipital
Feb 14, 2023

Chronic Low Back Pain Trial in United States (Oxycodone DETERx, Placebo)

Completed
Has Results
  • Chronic Low Back Pain
  • Oxycodone DETERx
  • Placebo
  • Mesa, Arizona
  • +44 more
Oct 15, 2020

Glioblastoma Trial in Boston, New York, Philadelphia (Pembrolizumab, Bevacizumab, Re-irradiation)

Active, not recruiting
  • Glioblastoma
  • Boston, Massachusetts
  • +4 more
Dec 7, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial (pembrolizumab, cisplatin, 5-FU)

Completed
Has Results
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • pembrolizumab
  • +3 more
  • (no location specified)
Jul 13, 2022

Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)

Not yet recruiting
  • Hepatitis C
  • Cirrhosis
  • (no location specified)
Jul 20, 2022

SARS-CoV2 Infection, Covid19, SARS-CoV-2 Acute Respiratory Disease Trial in Worldwide (BNT162b2, BNT162b2 (B.1.1.7 + B.1.617.2),

Active, not recruiting
  • SARS-CoV2 Infection
  • +3 more
  • BNT162b2
  • +5 more
  • Long Beach, California
  • +34 more
Jan 10, 2023

HIV, Clinical Outcomes, Adverse Drug Event Trial in Salvador, São Paulo (No intervention)

Recruiting
  • HIV Infections
  • +3 more
  • No intervention
  • Salvador, Bahia, Brazil
  • +2 more
Mar 15, 2022

Small Cell Lung Cancer Extensive Stage Trial in Jinan, Tianjin, Zhengzhou (IN10018, Tislelizumab, Carboplatin)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Jinan, China
  • +2 more
Sep 10, 2023

Metastatic Melanoma, Head Neck Cancer Trial in Worldwide (SD-101(1), Pembrolizumab, SD-101(2))

Terminated
Has Results
  • Metastatic Melanoma
  • Head Neck Cancer
  • Birmingham, Alabama
  • +46 more
Jul 12, 2021

Neovascular Age-related Macular Degeneration (NVAMD), Diabetic Macular Edema (DME) Trial in United States (EYE103)

Recruiting
  • Neovascular Age-related Macular Degeneration (NVAMD)
  • Diabetic Macular Edema (DME)
  • Phoenix, Arizona
  • +4 more
Jun 14, 2023

Patterns With Brolucizumab in Germany -Retrospective Cohort

Completed
  • Neovascular Age-related Macular Degeneration
    • Porto Salvo, Portugal
      Novartis
    Aug 28, 2023